|
|
||||||||
Articles |
Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, USA.
The recommendations provided in this document represent a distillation of various experiences, as well as data obtained from published studies in the setting of substantial changes in antibiotic sensitivity. It is hoped that this revised compilation will provide a basis upon which future developments and advances can be made in the therapeutic approach to infectious complications of peritoneal dialysis.
This article has been cited by other articles:
![]() |
C.-C. Szeto, B. C.-H. Kwan, K.-M. Chow, M.-F. Lau, M.-C. Law, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li Coagulase Negative Staphylococcal Peritonitis in Peritoneal Dialysis Patients: Review of 232 Consecutive Cases Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Warady, R. Feneberg, E. Verrina, J. T. Flynn, D. E. Muller-Wiefel, N. Besbas, A. Zurowska, N. Aksu, M. Fischbach, E. Sojo, et al. Peritonitis in Children Who Receive Long-Term Peritoneal Dialysis: A Prospective Evaluation of Therapeutic Guidelines J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2172 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Lockhart, B. Loven, M. T. Brennan, and P. C. Fox The evidence base for the efficacy of antibiotic prophylaxis in dental practice J Am Dent Assoc, April 1, 2007; 138(4): 458 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Szeto, K.-M. Chow, B. C.-H. Kwan, M.-C. Law, K.-Y. Chung, S. Yu, C.-B. Leung, and P. K.-T. Li Staphylococcus aureus Peritonitis Complicates Peritoneal Dialysis: Review of 245 Consecutive Cases Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 245 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Chow, C. C. Szeto, K. K.-T. Cheung, C. B. Leung, S. S.-H. Wong, M. C. Law, Y. W. Ho, and P. K.-T. Li Predictive Value of Dialysate Cell Counts in Peritonitis Complicating Peritoneal Dialysis Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 768 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Szeto, K.-M. Chow, K.-Y. Chung, B. Ching-Har Kwan, C.-B. Leung, and P. Kam-Tao Li The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2793 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Van Biesen, N. Veys, R. Vanholder, and N. Lameire Peritoneal-dialysis-related peritonitis: the art of rope-dancing Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1878 - 1882. [Full Text] [PDF] |
||||
![]() |
C.-C. Szeto, K.-M. Chow, T. Y.-H. Wong, C.-B. Leung, A. Y.-M. Wang, S.-F. Lui, and P. K.-T. Li Feasibility of Resuming Peritoneal Dialysis after Severe Peritonitis and Tenckhoff Catheter Removal J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. MANLEY, G. R. BAILIE, R. FRYE, L. D. HESS, and M. D. MCGOLDRICK Pharmacokinetics of Intermittent Intravenous Cefazolin and Tobramycin in Patients Treated with Automated Peritoneal Dialysis J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1310 - 1316. [Abstract] [Full Text] |
||||
![]() |
C. L. LOW, K. GOPALAKRISHNA, and W. C. LYE Pharmacokinetics of Once Daily Intraperitoneal Cefazolin in Continuous Ambulatory Peritoneal Dialysis Patients J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1117 - 1121. [Abstract] [Full Text] |
||||
![]() |
M. J. Hausmann, R. Yulzari, E. Lewis, Y. Saisky, and A. Douvdevani Gel clot LAL assay in the initial management of peritoneal dialysis patients with peritonitis: a retrospective study Nephrol. Dial. Transplant., May 1, 2000; 15(5): 680 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kuypers, J. Vanwalleghem, B. Maes, T. Messiaen, Y. Vanrenterghem, and W. E. Peetermans Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment Nephrol. Dial. Transplant., August 1, 1999; 14(8): 2050 - 2051. [Full Text] [PDF] |
||||
![]() |
C. A. Johnson, C. A. Taylor III, S. W. Zimmerman, W. E. Bridson, P. Chevalier, O. Pasquier, and R. I. Baybutt Pharmacokinetics of Quinupristin-Dalfopristin in Continuous Ambulatory Peritoneal Dialysis Patients Antimicrob. Agents Chemother., January 1, 1999; 43(1): 152 - 156. [Abstract] [Full Text] |
||||
![]() |
F. SCHAEFER, G. KLAUS, D. E. MÜLLER-WIEFEL, and O. MEHLS Intermittent versus Continuous Intraperitoneal Glycopeptide/Ceftazidime Treatment in Children with Peritoneal Dialysis-Associated Peritonitis J. Am. Soc. Nephrol., January 1, 1999; 10(1): 136 - 145. [Abstract] [Full Text] |
||||
![]() |
S. Pastan and J. Bailey Dialysis Therapy N. Engl. J. Med., May 14, 1998; 338(20): 1428 - 1437. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |